Comparison of Selected Genes in Curtis Breast Grouped by Cancer and Normal Type log2 median-centered intensity 1. Breast (144) 2. Benign Breast Neoplasm.

Slides:

Advertisements

Similar presentations

Tumor Board: Multidisciplinary Approach to Rare Breast Lesions Moderator: Aysegul A. Sahin, MD Panelists: Bruce Haffty Kelly K. Hunt Liane Philpotts Kalliopi.

Advertisements

DISEASES OF THE BREAST IN ACCRA Solomon E. Quayson MSc(Lond).,DIC.,FWACP.

Breast Pathology Helge Stalsberg MD University Hospital of North Norway.

Breast Cancer ECM Visualization using Multiphoton Imaging Jeremy Bredfeldt LOCI, Morgridge Institute for Research.

Histopathology and staging of breast cancer

Procedures used by CHTN

Breast Neoplasm In this section we will be discussing breast neoplasm.

Breast Imaging Made Brief and Simple

1 Breast MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.

Genetic and Molecular Epidemiology

SYB 1 Erin Gundersen MS IV. Breast Cancer Breast Cancer.

Breast Pathology. Breast pathology Inflammatory Disorders Acute Mastitis Preiductal Mastitis Mammary Duct Ectasia Fat Necrosis Lymphocytic Mastopathy.

FNA of breast Slide session The 6th Arab-British School of Pathology

Breast Cancer Awareness Marissa Gregg. What is Breast Cancer?  Breast Cancer forms in the breast  It is a tumor in the breast  Breast cancer is the.

Cancer Estimated US Cancer Cases Cancer Incidence Rates for Women, USA.

First month Second Month First month Second Month Milk line remnant Milk line remnant Accessory axillary breast tissue Accessory axillary breast tissue.

Imaging examinations of breasts

Division of Surgical, Molecular and Ultrastructural Pathology University of Pisa Pisa University Hospital Research Doctorate.

Breast disease MUDr. Petr Šafář, CSc.. Anatomy of female breast.

Objectives Discuss the history of breast cancer. Describe the pathology of breast cancer and list significant tumor markers. Differentiate IHC testing.

14-3-3ζ Cooperates with ErbB2 to Promote Ductal Carcinoma In Situ Progression to Invasive Breast Cancer by Inducing Epithelial-Mesenchymal Transition Jing.

Understanding Cancer and Related Topics

Oncology (onc- = tumor). Oncology (onco- = mass) -plasia = new development -trophy = growth –Changes in Growth sizeChanges in size of individual cell.

Date of download: 6/3/2016 Copyright © 2016 SPIE. All rights reserved. (a) Experimental setup to TPEF, SHG, THG, and FLIM microscopy. Real setup with different.

Supplemental Figure 1. Specificity of CCL2 and Fsp1 immunostaining of breast tumor tissues. Sections of invasive ductal carcinoma were incubated with primary.

Multistep model of breast cancer progression

Public Health Genomics 2012;15:1–10 - DOI: /

Diffuse Type Gastric and Lobular Breast Carcinoma in a Familial Gastric Cancer Patient with an E-Cadherin Germline Mutation Gisela Keller, Holger Vogelsang,

Invasive lobular breast cancer and its variants: How special are they for systemic therapy decisions? Séverine Guiu, Anita Wolfer, William Jacot, Pierre.

Invasive breast carcinoma

Contrast-enhanced Dedicated Breast CT: Initial Clinical Experience

Ductal carcinoma in situ (DCIS)

Invasive Breast Cancer Preferably and Predominantly Occurs at the Interface Between Fibroglandular and Adipose Tissue Wenlian Zhu, Susan Harvey, Katarzyna.

BREAST CANCER A full classification includes histopathological type, grade, stage (TNM), receptor status, and the presence or absence of genes as determined.

Patterns of ductal carcinoma in situ (DCIS)

From: Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force Ann Intern.

Invasive breast carcinoma

Ductal carcinoma in situ (DCIS)

Fig. 1. T2* relaxation time mapping from 55-year-old woman with ductal carcinoma in situ. A. Sagittal contrast-enhanced T1-weighted image shows heterogeneous.

Figure 1. MORT gene silencing is early event in cancer

Fig. 2. Screening breast MR images of 46-year-old woman with personal history of contralateral breast cancer.Breast MRI was reported as multiple benign.

Mammogram images (A, B) indicate an irregular mass in the upper outer left breast. Ultrasound of the left breast (C) shows this to be a solid, hypoechoic.

The benefits and harms of breast cancer screening

KDM1B Expression in Richardson Breast 2

Peter T. Simpson, Leonard M. Da Silva, Sunil R. Lakhani Cancer Cell

Ductal Carcinoma in Situ of the Breast

Noha Abd ElRahim Aboulhagag, Rana Fathy Torky, Sabah Ahmed Fadel

Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography Leslie R. Lamb, MD, MSc, Manisha Bahl, MD,

سرطان الثدي Breast Cancer

سرطان الثدي Breast Cancer

קבלת ההחלטה בנושא דרגת אי כושר

Volume 5, Issue 6, Pages (June 2004)

The immune metagene model has prognostic value in IBE but not in IBD breast cancer. The immune metagene model has prognostic value in IBE but not in IBD.

I. F. Anwar, S. K. Down, S. Rizvi, N. Farooq, A. Burger, A. Morgan, M

Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography Leslie R. Lamb, MD, MSc, Manisha Bahl, MD,

Cysteine cathepsins (proteases)—On the main stage of cancer?

Dr. V. J. Ekanem MBBCh, MSc, MHPM, FMCPath, FCPath (ECSA)

Volume 131, Issue 5, Pages (November 2006)

Frank C. Brosius, Subramaniam Pennathur Kidney International

ADAM8 is overexpressed in human breast cancer AADAM8 mRNA expression in samples from breast tumor and normal breast tissue was analyzed using the Oncomine.

Mammary stem cells and progenitors: targeting the roots of breast cancer for prevention (A) Schematic of the human breast highlighting terminal ductal.

FAK overexpression in invasive human breast cancer and DCIS

Reduced BAI1 expression is associated with breast cancer patient survival. Reduced BAI1 expression is associated with breast cancer patient survival. A,

MRNA expression IL-1α, IL-1β, IL-1Ra, IL-1RtI, ER α, ER β, and PR was analyzed by RT-PCR as described in “Materials and Methods.” Representative gel electrographies.

Principles and Practice of Radiation Therapy

Gene promoter methylation analysis in ductal lavage fluid from cancer-free women at high risk for breast cancer and in women undergoing mastectomy for.

In situ analysis of human breast tissue shows the down-regulation of Spry isoforms in breast cancer. In situ analysis of human breast tissue shows the.

Gene expression patterns of SLC and ABC transporters in normal and tumor tissues. Gene expression patterns of SLC and ABC transporters in normal and tumor.

Volume 12, Issue 6, Pages (December 2007)

Integrated analysis of gene expression and copy number alterations.

Presentation transcript:

Comparison of Selected Genes in Curtis Breast Grouped by Cancer and Normal Type log2 median-centered intensity 1. Breast (144) 2. Benign Breast Neoplasm (3) 3. Breast Carcinoma (14) 4. Breast Phyllodes Tumor (5) 5. Ductal Breast Carcinoma in Situ (10) 6. Invasive Breast Carcinoma (21) 7. Invasive Ductal and Invasive Lobular Breast Carcinoma (90) 8. Invasive Ductal Breast Carcinoma (1,556) 9. Invasive Lobular Breast Carcinoma (148) 10. Medullary Breast Carcinoma (32) 11. Mucinous Breast Carcinoma (46) 12. Tubular Breast Carcinoma (67) Copyright© Compendia Bioscience, Inc. Images from Oncomine™ may be used in publications with proper citation. The citation for Oncomine is as follows: Oncomine™ (Compendia Bioscience, Ann Arbor, MI) was used for analysis and visualization. For further information, refer to the terms described in the license agreement. Oncomine Source: 7,4216[ACC],7671,11868[FAS],13097,15953,17179,28049[CHREBP],31131,35251[GLUT1],35407,38168;scr:datasets;ss:all;th:g10.0,p1.000,fc2.0;v:17 Nature 2012/04/18, 2,136 samples, mRNA, 19,273 measured genes

Comparison of Selected Genes in Curtis Breast Grouped by Grade log2 median-centered intensity 0. No value (234) 1. Grade 1 (170) 2. Grade 2 (775) 3. Grade 3 (957) Note: Colors are z-score normalized to depict relative values within rows. They cannot be used to compare values between rows. Copyright© Compendia Bioscience, Inc. Images from Oncomine™ may be used in publications with proper citation. The citation for Oncomine is as follows: Oncomine™ (Compendia Bioscience, Ann Arbor, MI) was used for analysis and visualization. For further information, refer to the terms described in the license agreement. Oncomine Source: ;g:51085;p: ;pg:1;pvf:2967,13097,15953,28049[CHREBP],31131,35407,38168,159001;scr:datasets;ss:all;th:g10.0,p1.000,fc2.0;v:17

Comparison of Selected Genes in Curtis Breast Grouped by Grade log2 median-centered intensity 0. No value (234) 1. Grade 1 (170) 2. Grade 2 (775) 3. Grade 3 (957) Note: Colors are z-score normalized to depict relative values within rows. They cannot be used to compare values between rows. Copyright© Compendia Bioscience, Inc. Images from Oncomine™ may be used in publications with proper citation. The citation for Oncomine is as follows: Oncomine™ (Compendia Bioscience, Ann Arbor, MI) was used for analysis and visualization. For further information, refer to the terms described in the license agreement. Oncomine Source: